Clinical Trial Update: Study of Pomalidomide, Oral Dexamethasone and Ixazomib in Patients With Relapsed MM Who Have Received Lenalidomide [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating pomalidomide combined with dexamethasone and ixazomib in relapsed multiple myeloma patients previously treated with len…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)
• ixazomib (ixazomib)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Multiple Myeloma | Phase 4 | Status: UNKNOWN